ANZCTR search results

This trial was abandoned. The original protocol is not available so a brief summary is not available.

The medical, social and economic consequences of dysmenorrhoea are substantial and the prevalence studies emphasise dysmenorrhoea is an important women's health issue. The growing use of unproven complementary and alternative therapies by consumers highlights the need for scientifically rigorous research to identify those complementary and alternative therapies that are effective and safe. The Cochrane systematic review and small controlled trials suggest acupuncture may have a role in alleviating dysmenorrhoea. There is clearly a need for a large, pragmatic, well designed, randomised controlled trial to determine the effectiveness of acupuncture on dysmenorrhoea. The primary hypotheses of this study are that the use of acupuncture in women with dysmenorrhoea compared with sham acupuncture will 1. be effective at reducing their symptoms of dysmenorrhoea as measured by: a) reduced pain and duration of pain, b) reduced need for pain relief, c) an overall improvement in their symptoms, 2. improve their quality of life, as measured by a) improved quality of life indices, b) reduced time off work or from school, c) less restriction on daily life activities, d) less side effects from treatment, The secondary hypotheses of the study are the use of acupuncture in women with dysmenorrhoea compared with sham acupuncture will 1. be effective at meeting women’s expectations as measured by a) acceptability of treatment options for the treatment of dysmenorrhoea.

This randomised clinical trial will assess whether a slower, compared with the standard infusion rate of the loading dose of magnesium sulphate, given to women at risk of very preterm birth at less than 30 weeks gestation for fetal neuroprotection, is effective in reducing maternal adverse effects of treatment.

These data were not published because the quality of the EEG data was very poor. This was due to equipment malfunction.

In this pilot study, adult consumers attending primary care, the private sector and Southern Mental Health Services, who have had recurrent major depression will be randomised to one of four conditions: 1. Mindfulness-based cognitive therapy (MBCT) 2. Medication alliance therapy (MAT) 3. MBCT and MAT combined, and 4. Treatment as usual. Randomisation Strategy: Participants will be randomised to one of the four conditions. People either not prescribed or fully compliant with medication will have their randomisation options restricted to either Mindfulness-Based Cognitive Therapy or Treatment As Usual, because Medication Alliance Technology is not relevant to their situation. MBCT will be delivered by clinical psychologists trained according to the MBCT manual modified for an Australian context. MAT will be administered by community health staff, eg practice nurses, trained according to a manual developed by the research group. The research evaluation is at three levels: A. Examination of the feasibility of delivery of training programs and interventions within the Australian primary care context. B. Evaluation of the MBCT and MAT training packages, for which the participating therapists will be engaged also as study participants. C. Participating consumers will be regularly assessed over 12 months with systematic interviews assessing depression and disability as outcomes, and also mindfulness and adherence as possible mediating factors in the effects of these two therapies.

Australia has rising numbers of sexually transmissible infections, high levels of unprotected sex among young adults & a high teenage abortion rate. To address these public health priorities, we will use mobile phone text messaging (aka SMS) & email to send sexual health & contraception information to young men & women. A randomised controlled trial of the impact of text & email messages on sexual risk-taking will enable rigorous analysis of their efficacy and cost-effectiveness, & provide valuable data about how these cheap technologies could be used on a larger scale.